Our experts and support teams are based within National Health Service (NHS) organisations and universities throughout England. We support MedTech companies across all stages of product development: from identifying unmet clinical needs to designing and running clinical studies.
Areas of expertise covered include:
Our services are available for all types of MedTech companies including medical device diagnostics/technology, in vitro diagnostics (IVD), imaging and radiology. We also support non-life sciences companies including software developers and digital companies that are working on healthcare solutions.
Companies can access these resources at any stage in their product and clinical development process. Engaging with the NIHR at an early stage in your product development can provide real benefits, such as guidance on further development of the technology and early go/no go decisions.
The NIHR commissions and funds health, public health and social care research that is essential for improving the health and wealth of the nation.
Our research funding programmes span the research innovation pathway, from innovation and product development to evaluative research including large-scale clinical trials and post marketing studies.
Small and medium-sized enterprises (SMEs) are eligible to apply to a number of our funding programmes, either as a lead applicant, or a co-applicant with an academic or clinical partner.
The NIHR invention for Innovation (i4i) Programme supports development of innovative healthcare technologies. Its Connect funding stream is specifically designed for SMEs in need of a funding boost to reach the next stage in the development pathway.
Through our NIHR Medtech and In vitro diagnostics Co-operatives (MICs), we can help you to develop new medical technologies and provide evidence on commercially-supplied in vitro diagnostic (IVD) tests.
Based in leading NHS organisations, the MICs act as centres of expertise and bring together patients, clinicians, researchers, commissioners and industry.
The NIHR MICs launched on 1 January 2018, with than £14 million awarded across 11 NIHR MICs over 5 years until 2022:
MICs can help you to build a multi-disciplinary team that will work collaboratively with you to ensure you generate the evidence you need to support adoption of your medical device, digital technology or diagnostic in the NHS.
Get in touch:
If you are interested in working with the NIHR MICs or would like more information, please get in touch with: email@example.com.
Last year 111 MedTech companies and 25 Contract Research Organisations (CROs) accessed our Study Support Service. This service is free and helps companies and CROs to plan, set up and deliver high quality research on time and to target in our NHS. In total we supported 209 MedTech studies at various stages and and helped to recruit 13,373 participants into MedTech studies. This achieved through our national network which connects individual research sites to enable a ‘do once and share’ approach to study delivery, which means you benefit from country-wide expertise and experience.
Our services include:
Our research-ready workforce, based throughout the NHS, can help recruit patients to your study on a full cost recovery basis. We can also help you to connect and collaborate with patients who can help shape and improve the design and delivery of your study through our Patient Engagement in Clinical Development Service. This is a 'paid for' extension of our free Study Support Service.
You may also be interest to know how our services complement the paid-for support services that are provided by the National Institute for Health and Care Excellence (NICE). We've created an interactive image to help you navigate the different kinds of help and support available.
Or get in touch:
The NIHR Surgical Technology Evaluation Portal (STEP) provides companies and innovators with a single point of access to expert clinicians and research active surgeons in the NHS to help develop new surgical medical devices and technologies.
The resulting multidisciplinary teams can provide rapid feedback to the innovator and undertake high quality collaborative research. This can support the generation of evidence that could lead to faster and safer adoption of new surgical technologies into the NHS.
Get in touch:
Watch a webinar (slides with audio) that describes how the NIHR works in partnership with MedTech companies to help them successfully translate ideas into innovative medical technologies for use in the NHS.
Read case studies and watch related video content which describes how we support medical technology, device and diagnostic companies throughout the clinical development process
Working with us, Forte Medical Ltd ran a usability study to test Peezy - their device to improve urine sample collection
Developing a digital solution to help patients to regain their mobility
Developing the world's first patient-attached blood gas, electrolyte and metabolite monitoring system
Developing a device for earlier diagnosis of diagnosis of pre-cancerous colon polyps
NIHR-funded researchers have begun a new study on a bedside genetic test to predict whether newborn babies receiving antibiotics in intensive care are at risk of irreversible hearing loss.
NIHR-funded researchers will look at how novel methods of kidney MRI scanning can help improve diagnosis and treatment for people living with kidney disease.
Researchers at the University of Warwick Clinical Trials Unit are leading the Chronic Endometritis and Recurrent Miscarriage (CERM) trial, which aims to discover whether using the antibiotic doxycycline in women with the condition endometritis can improve their chances of having a baby and treat recurrent miscarriage by improving the balance of bacteria present in their reproductive system.
Researchers funded by the NIHR are developing new imaging technology to pinpoint prostate tumours in the operating theatre.
The NIHR has awarded more than £1 million to nine innovative medical technology projects led by small-to-medium enterprises (SMEs) that have the potential to improve outcomes for NHS patients.